The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission
Date
2019Journal
AIDS Research and Human RetrovirusesPublisher
Mary Ann Liebert Inc.Type
Review
Metadata
Show full item recordAbstract
Bacterial vaginosis (BV) is a common yet poorly understood vaginal condition that has become a major focus of HIV transmission and immunology research. Varied terminologies are used by clinicians and researchers to describe microbial communities that reside in the female reproductive tract (FRT), which is driven, in part, by microbial genetic and metabolic complexity, evolving diagnostic and molecular techniques, and multidisciplinary perspectives of clinicians, epidemiologists, microbiologists, and immunologists who all appreciate the scientific importance of understanding mechanisms that underlie BV. This Perspectives article aims to clarify the varied terms used to describe the cervicovaginal microbiota and its "nonoptimal" state, under the overarching term of BV. The ultimate goal is to move toward language standardization in future literature that facilitates a better understanding of the impact of BV on FRT immunology and risk of sexually transmitted infections, including HIV. © Lyle R. McKinnon et al. 2019; Published by Mary Ann Liebert, Inc. 2019.Sponsors
A.D.B. and L.R.M. are funded by the Canadian Institutes of Health Research (CIHR) grant TMI-138658. L.R.M. is supported by a CIHR New Investigator award and A.D.B. by the CIHR New Investigator in HIV award NIH-15404. R.K. is funded by CIHR grant PJT-156123. C.K. is funded by an Ontario HIV Treatment Network Applied HIV Chair award and operating grants and an HIV Team grant from CIHR. J.R. was supported by the National Institute for Allergy and Infectious Diseases of the National Institutes of Health under award number U19AI084044. G.T. is funded by the National Health and Medical Research Council of Australia Senior Research Fellowship GNT1117748. G.T. gratefully acknowledges the contribution of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.Keyword
bacterial vaginosisfemale reproductive tract
genital inflammation
HIV
HIV transmission
vaginal microbiota
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062412846&doi=10.1089%2faid.2018.0304&partnerID=40&md5=ef41b861ea1e9f02ef360c33971fb3e6; http://hdl.handle.net/10713/8707ae974a485f413a2113503eed53cd6c53
10.1089/aid.2018.0304
Scopus Count
Collections
Related articles
- Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
- Authors: Joag V, Obila O, Gajer P, Scott MC, Dizzell S, Humphrys M, Shahabi K, Huibner S, Shannon B, Tharao W, Mureithi M, Oyugi J, Kimani J, Kaushic C, Ravel J, Anzala O, Kaul R
- Issue date: 2019 May 2
- HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
- Authors: Mtshali A, Ngcapu S, Mindel A, Garrett N, Liebenberg L
- Issue date: 2021 Jun
- Bacterial vaginosis and the cervicovaginal immune response.
- Authors: Mitchell C, Marrazzo J
- Issue date: 2014 Jun
- Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
- Authors: Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V
- Issue date: 2015 May
- The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
- Authors: Reimers LL, Mehta SD, Massad LS, Burk RD, Xie X, Ravel J, Cohen MH, Palefsky JM, Weber KM, Xue X, Anastos K, Minkoff H, Atrio J, D'Souza G, Ye Q, Colie C, Zolnik CP, Spear GT, Strickler HD
- Issue date: 2016 Nov 1